Toggle Main Menu Toggle Search

Open Access padlockePrints

Sildenafil Citrate Augments Myocardial Protection in Heart Transplantation

Lookup NU author(s): Phil Botha, Dr Guy MacGowanORCiD, Professor John Dark


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Background. Sildenafil citrate has been shown to induce myocardial protective effects in a variety of experimental settings. Whether these effects could be used to enhance myocardial protection afforded by crystalloid cardioplegia, volatile anesthesia and hypothermia during cardiac transplantation remains to be established. Methods. We investigated the use of sildenafil-mediated cardioprotection in a rat model of heterotopic cardiac transplantation. Sildenafil citrate (0.7 mg/kg) was administered intravenously to the donor 30 min before onset of ischemia or 5 min before reperfusion in the recipient. In situ cardioplegic arrest was followed by an ischemic time of 3 or 6 hr, transplantation, and blood reperfusion. Myocardial functional recovery was studied in vivo by using a left ventricular balloon and cellular injury quantified by assay of troponin I release and apoptosis. Results. Sildenafil preconditioning but not postconditioning significantly improved initial myocardial systolic and diastolic function after 3 hr of hypothermic cardioplegic arrest (114 +/- 4 mm Hg vs. 83 +/- 4 min Hg generated pressure, [P<0.01]). The protective effect of sildenafil declined over a 3-hr period of reperfusion along with overall myocardial function, no longer reaching statistical significance at 3 hr. The protective effects of sildenafil were abolished by the putative blocker of the mitochondrial ATP sensitive potassium channel, 5-hydroxydecanoate, before sildenafil administration. Protein kinase C delta showed significant translocation after sildenafil administration in the donor. Conclusions. We conclude that sildenafil citrate pretreatment augments myocardial functional recovery after an ischemic time relevant to clinical cardiac transplantation. This effect is associated with protein kinase C activation/translocation and inhibited by 5-hydroxydecanoate.

Publication metadata

Author(s): Botha P, MacGowan GA, Dark JH

Publication type: Article

Publication status: Published

Journal: Transplantation

Year: 2010

Volume: 89

Issue: 2

Pages: 169-177

Print publication date: 01/01/2010

ISSN (print): 0041-1337

ISSN (electronic): 1534-6080

Publisher: Lippincott Williams & Wilkins


DOI: 10.1097/TP.0b013e3181c42b22


Altmetrics provided by Altmetric